Asia Deal Watch: Maruho Licenses Rights In Japan To GI Innovation’s Allergy Candidate

 
• By Jung Won Shin, Vibha Ravi, Lisa Takagi, and Joseph Haas

Plus deals involving BioLineRx/GloriaBio, Healios/Athersys, Aurobindo/Hilleman, Lupin/Menarini, GC Biopharma/Immetas, CanariaBio, Specialised Therapeutics, TaiGen/Y.S.P., Nippon/Kayaku/Adlai Nortye, WuXi/PharmaEssentia, Evommune/Maruho and Ono/Adimab.

Asia Deal Watch
• Source: Alamy

More from Deal Watch

More from Deals